Results 191 to 200 of about 16,830 (216)

Quantitative proteomic analysis identifies novel regulators of methotrexate resistance in choriocarcinoma

Gynecologic Oncology, 2020
Fu Jun, Dazun Shi, Zheng Peng
exaly  

Intraplacental choriocarcinoma associated with viable pregnancy: pathologic features and implications for the mother and infant.

Pediatric and Developmental Pathology, 1998
Suzanne M Jacques, Faisal Qureshi, Barbara J Doss   +2 more
exaly  

Successful treatment of metastatic refractory gestational choriocarcinoma with pembrolizumab: A case for immune checkpoint salvage therapy in trophoblastic tumors

Gynecologic Oncology Reports, 2020
Nicolas Gallegos
exaly  

Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma

Cancer Letters, 2010
Chin-Jung Wang, Yun-Shien Lee, An-Shine Chao   +2 more
exaly  

Intraplacental choriocarcinoma: Systematic review and management guidance

Gynecologic Oncology, 2016
Neil J. Sebire, Michael J Seckl, M J Seckl   +2 more
exaly  

Choriocarcinoma: A model for tumour markers

Acta Oncológica, 1992
Kenneth D Bagshawe, K D Bagshawe
exaly  

Primary Ovary Choriocarcinoma: Individual DNA Polymorphic Analysis as a Strategy to Confirm Diagnosis and Treatment

Rare Tumors, 2013
Cristina Anton, Tiago Kenji Takahashi
exaly  

The Early History of Choriocarcinoma*

Journal of the History of Medicine and Allied Sciences, 1961
W B, OBER, R O, FASS
openaire   +3 more sources

Gestational choriocarcinoma of the ovary diagnosed by analysis of tumour DNA

Cancer Letters, 1996
Andrew Grierson, Paul Lorigan, M H Goyns
exaly  

Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment

Drug Delivery, 2018
Lintao Cai, Mingbin Zheng
exaly